Cancer Letters
The opportunities and challenges in immunotherapy: Insights from the regulation of PD-L1 in cancer cells
Publication date: Available online 15 July 2023Source: Cancer LettersAuthor(s): Qingyu Lin, Xingwen Wang, Ying Hu
Cancer Letters
Gut fungal mycobiome: A significant factor of tumor occurrence and development
Publication date: Available online 13 July 2023Source: Cancer LettersAuthor(s): Fan Li, Yunhuan Gao, Wenyue Cheng, Xiaomin Su, Rongcun Yang
Cancer Letters
Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence
Publication date: Available online 12 July 2023Source: Cancer LettersAuthor(s): Yi Qin, Milad Ashrafizadeh, Vera Mongiardini, Benedetto Grimaldi, Francesco Crea, Katja Rietdorf, Balázs Győrffy, Daniel J. Klionsky, Jun Ren, Wei Zhang, Xianbin Zhang
Cancer Letters
Acidosis-induced regulation of adipocyte G0S2 promotes crosstalk between adipocytes and breast cancer cells as well as tumor progression
Publication date: Available online 11 July 2023Source: Cancer LettersAuthor(s): Julie Cremer, Laura Brohée, Laura Dupont, Camille Lefevre, Raphaël Peiffer, Alicia M. Saarinen, Olivier Peulen, Laure Bindels, Jun Liu, Alain Colige, Christophe F. Deroanne
Cancer Letters
Corrigendum to “PHF14 knockdown causes apoptosis by inducing DNA damage and impairing the activity of the damage response complex in colorectal cancer” [Cancer Lett. 531 (2022) 109–123]
Publication date: Available online 10 July 2023Source: Cancer LettersAuthor(s): Guangzhao Pan, Kui Zhang, Shengjun Geng, Chao Lan, Xin Hu, Changhong Li, Haoyan Ji, Chongyang Li, Xiaosong Hu, Yi Wang, Muhan Lv, Hongjuan Cui
Cancer Letters
Corrigendum to “Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells” [Cancer Lett. 412 (2018) 297-307]
Publication date: Available online 7 July 2023Source: Cancer LettersAuthor(s): Huong Thuy Le, Huy Truong Nguyen, Hye-Young Min, Seung Yeob Hyun, Soonbum Kwon, Yeongcheol Lee, Thi Hong Van Le, Jeeyeon Lee, Jeong Hill Park, Ho-Young Lee
Cancer Letters
Corrigendum to “Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype” [Cancer Lett. 435 (28 October 2018) 80-91]
Publication date: Available online 8 July 2023Source: Cancer LettersAuthor(s): Xin Chen, Jieru Zhou, Xiaoduan Li, Xinjing Wang, Yingying Lin, Xipeng Wang
Cancer Letters
Corrigendum to “A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis” [Cancer Lett. 520 (2021) 321–331]
Publication date: Available online 8 July 2023Source: Cancer LettersAuthor(s): Tingting Wang, Zhenchuan Liu, Yunlang She, Jiajun Deng, Yifan Zhong, Mengmeng Zhao, Shenghui Li, Dong Xie, Xiwen Sun, Xuefei Hu, Chang Chen
Cancer Letters
HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complex
Publication date: Available online 7 July 2023Source: Cancer LettersAuthor(s): Ping Zhao, Fei Yuan, Lijuan Xu, Zhenghao Jin, Yang Liu, Jing Su, Lin Yuan, Lei Peng, Chaofu Wang, Guoxin Zhang
Cancer Letters
A novel microenvironment regulated system CAR-T (MRS.CAR-T) for immunotherapeutic treatment of esophageal squamous carcinoma
Publication date: Available online 7 July 2023Source: Cancer LettersAuthor(s): Lihong Wang, Xiaosa Wang, Yangyang Wu, Jingjing Wang, Wenping Zhou, Jianyao Wang, Haoran Guo, Na Zhang, Lufang Zhang, Xuanyu Hu, Yuanyuan Zhao, Jinxin Miao, Zifang Zhang, Lo…